Sign in

CIK 0001585364 · Large accelerated filer

PERRIGO Co plc

Sign in to watch
Ticker
PRGO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
operating
Phone
269-673-8451
Business address
THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
Former names
PERRIGO Co Ltd
  1. 4 Option exercise EVP & President CSCA acquired 5,733 shares (option exercise)
  2. 4 Option exercise CEO acquired 17,835 shares (option exercise)
  3. 4 Option exercise EVP & CHRO acquired 2,070 shares (option exercise)
  4. 4/A Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale EVP, Gbl Ops & SC & CTO sold 7,800 shares at $27.44 ($214,032)
  7. 4 Grant or award EVP & CHRO acquired 12,762 shares (grant or award)
  8. 4 Grant or award EVP & Chief Financial Officer acquired 26,738 shares (grant or award)
  9. 4 Grant or award CEO acquired 16,389 shares (grant or award)
  10. 4 Option exercise Director acquired 5,548 shares (option exercise)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Director sold 17,598 shares at $28.27 ($497,495)
  13. 4 Option exercise EVP & President CSCA acquired 3,611 shares (option exercise)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Director sold 8,954 shares at $27.30 ($244,444)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale EVP, Gbl Ops & SC & CTO sold 13,000 shares at $29.40 ($382,246)
  18. 4 Open-market sale EVP & President CHCI sold 34,983 shares at an average $27.69 ($968,560)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 6 of 41 · 805 filings